ZB4-71386-04104
5 vaccinations
5 coded responses
44 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 850 / AZ
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
- 2021-01-18
- 2021-01-19
-
2021-01-26
Survey response — day 14, dose 1MedDRA: Eye swelling, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: I developed a bubble on my right eye. Possible abnormal conjunctivitis-like symptoms. · Healthcare visit (other): OphthalmologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-02
Dose 2 — Pfizer-BioNTech
-
2021-02-02
Survey response — day 21, dose 1MedDRA: Emergency care, Scleral disorder, Specialist consultation — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I had an unexpected bubble form on the white of my right eye. Went to the ophthalmologist, who proscribed steroid drops. The event may/may not be related to C19 and/or first shot (01.12.21). 2nd shot is tomorrow at 12:34AM. · Healthcare visit (other): Ophthalmologist emergency visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-18
-
2021-04-08
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-05-04
- 2021-08-03
-
2021-09-14
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
-
2021-12-14
Survey response — 3 months, dose 3MedDRA: Headache, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Stuffiness and persistent headache for se ral days.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-15
-
2022-04-11
Dose 4 — Pfizer-BioNTech
-
2022-04-14
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-25
- 2022-05-04
-
2022-05-09
Survey response — day 28, dose 4MedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Nasal drip and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-16
- 2022-05-23
- 2022-07-11
-
2022-09-23
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-24
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-25
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
-
2022-12-23
Survey response — 3 months, dose 5MedDRA: Cough, Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Congestion, runny nose, cough, 1-day of fever--cough lasted 3 weeks.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-09-14 | Pfizer-BioNTech | No |
| 4 | 2022-04-11 | Pfizer-BioNTech | No |
| 5 | 2022-09-23 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-26 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-02-02 | Successful 2021-04-08 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 2 — day 14, dose 1
Symptoms: I developed a bubble on my right eye. Possible abnormal conjunctivitis-like symptoms.
Healthcare visit (other): Ophthalmologist
Release 3 — day 21, dose 1
Symptoms: I had an unexpected bubble form on the white of my right eye. Went to the ophthalmologist, who proscribed steroid drops. The event may/may not be related to C19 and/or first shot (01.12.21). 2nd shot is tomorrow at 12:34AM.
Healthcare visit (other): Ophthalmologist emergency visit
Release 10 — 3 months, dose 3
Symptoms: Stuffiness and persistent headache for se ral days.
Release 11 — day 28, dose 4
Symptoms: Nasal drip and congestion
Release 12 — 3 months, dose 5
Symptoms: Congestion, runny nose, cough, 1-day of fever--cough lasted 3 weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Eye swelling | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Scleral disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release